• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 10, 2023 at 10:22: AM
via
  • Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the company in oncology
  • Advancing the use of bicycle peptides as a novel targeting approach in radiopharmaceuticals

article source
 




Top Bottom
Back
Quote